G1 THERAPEUTICS INC's ticker is GTHX and the CUSIP is 3621LQ109. A total of 118 filers reported holding G1 THERAPEUTICS INC in Q3 2018. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $0 | -100.0% | 90 | -89.1% | 0.00% | – |
| Q2 2023 | $2,000 | 0.0% | 825 | +22.0% | 0.00% | – |
| Q1 2023 | $2,000 | -71.4% | 676 | -52.6% | 0.00% | – |
| Q4 2022 | $7,000 | -66.7% | 1,426 | -12.7% | 0.00% | – |
| Q3 2022 | $21,000 | +2000.0% | 1,633 | +311.3% | 0.00% | – |
| Q2 2022 | $1,000 | -95.5% | 397 | -85.8% | 0.00% | – |
| Q1 2022 | $22,000 | -75.8% | 2,801 | -68.4% | 0.00% | – |
| Q4 2021 | $91,000 | +28.2% | 8,859 | +68.6% | 0.00% | – |
| Q3 2021 | $71,000 | +2.9% | 5,254 | +69.0% | 0.00% | – |
| Q2 2021 | $69,000 | -2.8% | 3,109 | +5.1% | 0.00% | – |
| Q1 2021 | $71,000 | +294.4% | 2,958 | +192.0% | 0.00% | – |
| Q4 2020 | $18,000 | +1700.0% | 1,013 | +704.0% | 0.00% | – |
| Q3 2020 | $1,000 | -66.7% | 126 | -6.7% | 0.00% | – |
| Q2 2020 | $3,000 | -50.0% | 135 | -76.8% | 0.00% | – |
| Q1 2020 | $6,000 | -83.3% | 582 | -57.9% | 0.00% | – |
| Q4 2019 | $36,000 | +500.0% | 1,381 | +473.0% | 0.00% | – |
| Q3 2019 | $6,000 | +50.0% | 241 | +91.3% | 0.00% | – |
| Q2 2019 | $4,000 | +100.0% | 126 | 0.0% | 0.00% | – |
| Q1 2019 | $2,000 | 0.0% | 126 | 0.0% | 0.00% | – |
| Q4 2018 | $2,000 | -93.9% | 126 | -79.6% | 0.00% | – |
| Q3 2018 | $33,000 | +450.0% | 619 | +301.9% | 0.00% | – |
| Q2 2018 | $6,000 | +100.0% | 154 | -4.3% | 0.00% | – |
| Q4 2017 | $3,000 | -81.2% | 161 | -74.9% | 0.00% | – |
| Q3 2017 | $16,000 | – | 641 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 98,482 | $1,631,000 | 0.60% |
| Opus Point Partners Management, LLC | 20,844 | $346,000 | 0.47% |
| HHLR ADVISORS, LTD. | 949,431 | $15,761,000 | 0.44% |
| Rhenman & Partners Asset Management AB | 212,169 | $3,522,000 | 0.41% |
| Virtus ETF Advisers LLC | 8,654 | $144,000 | 0.31% |
| BB BIOTECH AG | 671,925 | $11,154,000 | 0.28% |
| RA Capital Management | 363,051 | $6,027,000 | 0.26% |
| BDO Wealth Advisors, LLC | 35,234 | $585,000 | 0.17% |
| Birchview Capital, LP | 15,000 | $249,000 | 0.16% |
| SECOR Capital Advisors, LP | 37,205 | $618,000 | 0.13% |